Bioregenx, Inc.
FDIT
Revenue
445.97k
▼-69.18k▼-13.43%
3 Months ChangeAssets
1.15M
▲667.94k▲138.40%
3 Months ChangeLiabilities
4.81M
▲763.72k▲18.90%
3 Months ChangeFree Cash Flow
37.70k
▲331.34k▲112.84%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-06-11
Form 8-K
ID: 0001683168-24-004095
2024-05-24
Form 10-Q
ID: 0001683168-24-003807
2024-05-16
Form 8-K
ID: 0001683168-24-003582
2024-04-01
Form 8-K
ID: 0001683168-24-001917
2023-11-20
Form 10-Q
ID: 0001683168-23-008360
2023-08-15
Form 10-Q
ID: 0001683168-23-005813
2023-05-22
Form 10-Q
ID: 0001683168-23-003620
2023-01-06
Form 8-K
ID: 0001800943-23-000001
2022-11-21
Form 10-Q
ID: 0001800943-22-000015
2022-08-12
Form 10-Q
ID: 0001800943-22-000013